<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02700607</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1160101</org_study_id>
    <nct_id>NCT02700607</nct_id>
  </id_info>
  <brief_title>Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity</brief_title>
  <official_title>Impact of Intravascular Fluid Resuscitation on Whole Blood Viscosity During Coiling Embolization Procedure for Cerebral Artery Aneurysm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After obtaining approval from the Institutional Review Board of our institution, written&#xD;
      informed consent is obtained from patients undergoing interventional cerebral aneurysm&#xD;
      coiling procedure are enrolled in this prospective study and randomly allocated into one of&#xD;
      two groups: Group-C (n=10) and Group-HES (n=10).&#xD;
&#xD;
      All recruited patients will be given patient identification number (PIN) for the present&#xD;
      study of 01-20 according to their order of interview and recruitment. Investigators will&#xD;
      prepare 10 yellow and 10 green cards, which will be inserted in 20 thick-paper envelopes.&#xD;
      Then, all envelopes will be sealed, mixed and randomly allocated to get numbers of 01 to 20&#xD;
      (Envelop number). After printing the envelope number outside envelope, all sealed envelopes&#xD;
      with cards will be conveyed to and kept in pharmacy department.&#xD;
&#xD;
      According to the color of the card, attending anesthesiologists will give crystalloid for&#xD;
      yellow card or HES for green cards, respectively, to maintain stroke volume variation &lt; 15&#xD;
      during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture.&#xD;
&#xD;
      Patient data and statistical analyses:&#xD;
&#xD;
      Patient's data whole blood viscosity, PaO2, FiO2, Hemoglobin, urine amount, s-glucose will be&#xD;
      determined from the patients' medical record after patient's discharge.&#xD;
&#xD;
      All statistical analyses will be performed after the 20th patient's discharge and data&#xD;
      acquisition&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2016</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>whole blood viscosity</measure>
    <time_frame>with 1 hour after the completion of procedure</time_frame>
    <description>whole blood viscosity measured by viscometer cm-1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PaO2/FiO2 ratio</measure>
    <time_frame>1 hour after the completion of procedure</time_frame>
    <description>PaO2/FiO2 ratio measured by arterial blood gas analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hematocrit</measure>
    <time_frame>1 hour after the completion of procedure</time_frame>
    <description>serum hematocrit, %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose</measure>
    <time_frame>1 hour after the completion of procedure</time_frame>
    <description>serum glucose level, g/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>osmolarity</measure>
    <time_frame>1 hour after the completion of procedure</time_frame>
    <description>serum osmolarity, mosm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urine output</measure>
    <time_frame>1 hour after the completion of procedure</time_frame>
    <description>hourly urine output, ml/hr</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cerebral Aneurysm</condition>
  <arm_group>
    <arm_group_label>Intravenous Crystalloid</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>crystalloid is administered to maintain stroke volume variation &lt; 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous HES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HES is administered to maintain stroke volume variation &lt; 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous Crystalloid</intervention_name>
    <description>crystalloid is administered to maintain stroke volume variation &lt; 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture</description>
    <arm_group_label>Intravenous Crystalloid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous HES</intervention_name>
    <description>HES is administered to maintain stroke volume variation &lt; 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture</description>
    <arm_group_label>Intravenous HES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing coiling embolization procedure due to cerebral aneurysm&#xD;
&#xD;
          -  Patients provided a written informed consent.&#xD;
&#xD;
          -  Patients with preoperative serum hemoglobin concentration &gt;13 g/dL (male) and &gt;12 g/dL&#xD;
             (female)&#xD;
&#xD;
          -  Patients with PaO2/FiO2 ratio &gt;150&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with history of anemia, dyspnea, active infection.&#xD;
&#xD;
          -  Patients with endocrine disease&#xD;
&#xD;
          -  Patients received or receiving intraoperative and preoperative blood salvaged,&#xD;
             allogenic blood transfusion, anti-platelet drug, anti-fibrinolytic agents or&#xD;
             recombinant human erythropoietin, or undergoing acute normovolemic hemodilution.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 23, 2016</study_first_submitted>
  <study_first_submitted_qc>March 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2016</study_first_posted>
  <last_update_submitted>July 17, 2019</last_update_submitted>
  <last_update_submitted_qc>July 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cerebral aneurysm, coiling embolization, blood viscosity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

